Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study.

Matthias HepprichDaniela ZilligManuel A Florian-ReynosoMarc Y DonathGottfried Rudofsky

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)

Switching to semaglutide from established GLP-1 analogue therapy improved HbA1c and body weight. Both equipotential and stepwise dosing initiation appear to be effective and well tolerated.

Keyphrases

body weight
bone marrow